دورية أكاديمية

Higher CD4 + CD40 +  T cells (Th40 cells) associate with systemic lupus erythematosus activity.

التفاصيل البيبلوغرافية
العنوان: Higher CD4 + CD40 +  T cells (Th40 cells) associate with systemic lupus erythematosus activity.
المؤلفون: Zhu L; Department of Rheumatology and Immunology, First Affiliated Hospital, Jinan University, Guangzhou, 510632, China. zhulihua20121113@163.com.; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China. zhulihua20121113@163.com., Song G; Department of Rheumatology and Immunology, First Affiliated Hospital, Jinan University, Guangzhou, 510632, China., Chen X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Zhang Y; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Cui Y; Department of Rheumatology and Immunology, First Affiliated Hospital, Jinan University, Guangzhou, 510632, China., Qiao J; Department of Rheumatology and Immunology, First Affiliated Hospital, Jinan University, Guangzhou, 510632, China., Huang X; Department of Rheumatology and Immunology, First Affiliated Hospital, Jinan University, Guangzhou, 510632, China., Li X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Liu X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Zeng X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Li Y; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China., Wang L; Department of Oncology, First Affiliated Hospital, Jinan University, Guangzhou, 510632, China. wangliang@jnu.edu.cn., Li B; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China. jnlibo517@163.com.
المصدر: Scientific reports [Sci Rep] 2023 Jul 03; Vol. 13 (1), pp. 10702. Date of Electronic Publication: 2023 Jul 03.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: Serositis* , Lupus Erythematosus, Systemic* , Pneumonia*, Humans ; Interleukin-10 ; Interleukin-6 ; Tumor Necrosis Factor-alpha ; Interleukin-2 ; Interleukin-4
مستخلص: The aim of this study was to investigate the characteristics of CD4 + CD40 +  T cells (Th40 cells) in Chinese systemic lupus erythematosus (SLE) patients. Flow cytometry was used to identify the percentage of Th40 cells in peripheral blood from 24 SLE patients and 24 healthy individuals and the level of IL-2, IL-4, IL-6, IL-10, IFN-r, and TNF-α in serum (22 cases) from the SLE patients. Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2000) was used to assess the SLE disease active state. The percentage of Th40 cells in T cells from SLE patients (19.37 ± 17.43) (%) was significantly higher than that from healthy individuals (4.52 ± 3.16) (%) (P < 0.001). The percentage of Th40 cells was also positively associated with SLEDAI-2000 (P = 0.001) and negatively associated with complement C3 (P = 0.007). The Th40 cell percentage was different in SLE patients with different organs involved. The Th40 cell percentage in SLE patients with lupus serositis (29.29 ± 22.19) was significantly higher than that in patients without serositis (13.41 ± 10.79; P = 0.040), and the percentage in SLE patients with lupus pneumonia involvement (29.11 ± 11.88) was significantly higher than that in patients without lupus pneumonia (16.80 ± 17.99; P = 0.043). After 4 weeks treatment, the Th40 cell percentage decreased significantly (P = 0.005). However, Th40 cell expression was not related to cytokines (IL-2, IL-4, IL-6, IL-10, IFN-r, and TNF-α; P > 0.05). A significantly higher percentage of Th40 cells was found in SLE patients, and the Th40 cell percentage was associated with SLE activity. Thus, Th40 cells may be used as a predictor for SLE disease activity and severity and therapeutic efficacy.
(© 2023. The Author(s).)
References: Diabetologia. 2014 Nov;57(11):2366-73. (PMID: 25104468)
Eur J Immunol. 2004 May;34(5):1488-97. (PMID: 15114683)
Nat Rev Immunol. 2018 Dec;18(12):773-789. (PMID: 30254251)
J Clin Endocrinol Metab. 2019 Sep 1;104(9):4127-4142. (PMID: 31063181)
Mol Med Rep. 2018 Mar;17(3):3489-3496. (PMID: 29286106)
Clin Immunol. 2007 Aug;124(2):138-48. (PMID: 17560173)
PLoS One. 2017 Feb 13;12(2):e0172037. (PMID: 28192476)
Lupus. 2001;10(5):319-20. (PMID: 11403261)
J Neuroimmunol. 2014 May 15;270(1-2):75-85. (PMID: 24690203)
Int J Mol Med. 1999 Sep;4(3):231-42. (PMID: 10425271)
Arthritis Res Ther. 2008;10(6):227. (PMID: 19040771)
Front Immunol. 2019 Apr 15;10:772. (PMID: 31037070)
J Leukoc Biol. 2008 Aug;84(2):431-9. (PMID: 18469093)
Eur J Immunol. 2012 Feb;42(2):424-35. (PMID: 22105491)
Rheumatol Int. 2016 Jun;36(6):799-805. (PMID: 26769434)
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3782-7. (PMID: 11891296)
J Transl Med. 2021 Jan 19;19(1):35. (PMID: 33468161)
المشرفين على المادة: 130068-27-8 (Interleukin-10)
0 (Interleukin-6)
0 (Tumor Necrosis Factor-alpha)
0 (Interleukin-2)
207137-56-2 (Interleukin-4)
تواريخ الأحداث: Date Created: 20230703 Date Completed: 20230705 Latest Revision: 20230706
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10317960
DOI: 10.1038/s41598-023-37749-y
PMID: 37400575
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-023-37749-y